Healthcare >> CEO Interviews >> March 21, 2005

Schond Greenway – Durect Corporation (drrx)

SCHOND L. GREENWAY is Executive Director of Investor Relations and Strategic Planning for DURECT Corporation. Mr. Greenway is primarily responsible for a variety of duties including the development and execution of investor relations programs, providing planning and counsel on strategy, positioning, message development and the integration of marketing communications into the overall financial communications activities. He also assists in managing investment banking, equity research and institutional and retail investor relationships. Mr. Greenway is also responsible for providing strategic advice and counsel to executive management and the Board of Directors with respect to corporate financing activities and the evaluation of new business and product investment opportunities. Mr. Greenway joined DURECT in September 2000 as Director of Investor Relations and was promoted to Senior Director of Investor Relations and Strategic Planning in 2001. Prior to joining DURECT, Mr. Greenway held various positions at Morgan Stanley. His last position was as a Senior Associate in the investment banking division, where he gained corporate finance and M&A experience, completing over $9 billion in transactions in industries such as technology, telecommunications, health care and general industrials. Mr. Greenway earned his MBA from the Darden Graduate School of Business Administration at the University of Virginia. He also received a BS in Computer Information Systems from Florida A&M University. Mr. Greenway received an honorable discharge from the United States Air Force Reserves in 1993. Profile
TWST: Could we begin with a brief historical sketch of DURECT

Corporation and a picture of things as they are now?

Mr. Greenway: DURECT Corporation is an emerging specialty